May 2006 - Volume 47 - Issue 5 - Contributor Index

Alphabetical Search
Q
U
Author:
Abesser, Marco
Author:
BY, Wang
Author:
Cohen, Hofit MD
Author:
CQ, Wang
Author:
DJ, Huang
Author:
Ertl, Georg MD
Author:
Eto, Masato MD
Author:
Frishman, Liron

Functional and Bioenergetic Consequences of AT1 Antagonist Olmesartan Medoxomil in Hearts With Postinfarction LV Remodeling

Ochiai, Koichi; Hu, Qingsong; Lee, Joseph; More

Journal of Cardiovascular Pharmacology . 47(5):686-694, May 2006.

Author:
Harats, Dror MD
Author:
HH, Fan

Functional and Bioenergetic Consequences of AT1 Antagonist Olmesartan Medoxomil in Hearts With Postinfarction LV Remodeling

Ochiai, Koichi; Hu, Qingsong; Lee, Joseph; More

Journal of Cardiovascular Pharmacology . 47(5):686-694, May 2006.

Author:
HY, Ding

Functional and Bioenergetic Consequences of AT1 Antagonist Olmesartan Medoxomil in Hearts With Postinfarction LV Remodeling

Ochiai, Koichi; Hu, Qingsong; Lee, Joseph; More

Journal of Cardiovascular Pharmacology . 47(5):686-694, May 2006.

Author:
J, Gu
Author:
Lee, Joseph BS

Functional and Bioenergetic Consequences of AT1 Antagonist Olmesartan Medoxomil in Hearts With Postinfarction LV Remodeling

Ochiai, Koichi; Hu, Qingsong; Lee, Joseph; More

Journal of Cardiovascular Pharmacology . 47(5):686-694, May 2006.

Functional and Bioenergetic Consequences of AT1 Antagonist Olmesartan Medoxomil in Hearts With Postinfarction LV Remodeling

Ochiai, Koichi; Hu, Qingsong; Lee, Joseph; More

Journal of Cardiovascular Pharmacology . 47(5):686-694, May 2006.

Functional and Bioenergetic Consequences of AT1 Antagonist Olmesartan Medoxomil in Hearts With Postinfarction LV Remodeling

Ochiai, Koichi; Hu, Qingsong; Lee, Joseph; More

Journal of Cardiovascular Pharmacology . 47(5):686-694, May 2006.

Functional and Bioenergetic Consequences of AT1 Antagonist Olmesartan Medoxomil in Hearts With Postinfarction LV Remodeling

Ochiai, Koichi; Hu, Qingsong; Lee, Joseph; More

Journal of Cardiovascular Pharmacology . 47(5):686-694, May 2006.

Author:
Music, Ivana MD

The D3-dopaminergic Agonist 7-hydroxy-dipropylaminotetralin (7-OH-DPAT) Increases Cardiac Action Potential Duration and Blocks Human Ether-a-go-go-related Gene K+ Channel

Torres-Jácome, Julián; Tejeda-Chávez, Hector R.; Rodríguez-Menchaca, Aldo A.; More

Journal of Cardiovascular Pharmacology . 47(5):656-662, May 2006.

Author:
Obad, Ante MD

Functional and Bioenergetic Consequences of AT1 Antagonist Olmesartan Medoxomil in Hearts With Postinfarction LV Remodeling

Ochiai, Koichi; Hu, Qingsong; Lee, Joseph; More

Journal of Cardiovascular Pharmacology . 47(5):686-694, May 2006.

Author:
Palada, Ivan MD
Author:
Peled, Michael
Author:
Rathgeb, Lisa

The D3-dopaminergic Agonist 7-hydroxy-dipropylaminotetralin (7-OH-DPAT) Increases Cardiac Action Potential Duration and Blocks Human Ether-a-go-go-related Gene K+ Channel

Torres-Jácome, Julián; Tejeda-Chávez, Hector R.; Rodríguez-Menchaca, Aldo A.; More

Journal of Cardiovascular Pharmacology . 47(5):656-662, May 2006.

Author:
Sadan, Gulay MD

The D3-dopaminergic Agonist 7-hydroxy-dipropylaminotetralin (7-OH-DPAT) Increases Cardiac Action Potential Duration and Blocks Human Ether-a-go-go-related Gene K+ Channel

Torres-Jácome, Julián; Tejeda-Chávez, Hector R.; Rodríguez-Menchaca, Aldo A.; More

Journal of Cardiovascular Pharmacology . 47(5):656-662, May 2006.

Author:
Seto, Shinji MD
Author:
Shi, Yan Fen

Functional and Bioenergetic Consequences of AT1 Antagonist Olmesartan Medoxomil in Hearts With Postinfarction LV Remodeling

Ochiai, Koichi; Hu, Qingsong; Lee, Joseph; More

Journal of Cardiovascular Pharmacology . 47(5):686-694, May 2006.

Author:
Tal, Reshef

The D3-dopaminergic Agonist 7-hydroxy-dipropylaminotetralin (7-OH-DPAT) Increases Cardiac Action Potential Duration and Blocks Human Ether-a-go-go-related Gene K+ Channel

Torres-Jácome, Julián; Tejeda-Chávez, Hector R.; Rodríguez-Menchaca, Aldo A.; More

Journal of Cardiovascular Pharmacology . 47(5):656-662, May 2006.

The D3-dopaminergic Agonist 7-hydroxy-dipropylaminotetralin (7-OH-DPAT) Increases Cardiac Action Potential Duration and Blocks Human Ether-a-go-go-related Gene K+ Channel

Torres-Jácome, Julián; Tejeda-Chávez, Hector R.; Rodríguez-Menchaca, Aldo A.; More

Journal of Cardiovascular Pharmacology . 47(5):656-662, May 2006.

Functional and Bioenergetic Consequences of AT1 Antagonist Olmesartan Medoxomil in Hearts With Postinfarction LV Remodeling

Ochiai, Koichi; Hu, Qingsong; Lee, Joseph; More

Journal of Cardiovascular Pharmacology . 47(5):686-694, May 2006.

Author:
XL, Xie
Author:
Xue, Chun MD
Author:
YM, Xu

Functional and Bioenergetic Consequences of AT1 Antagonist Olmesartan Medoxomil in Hearts With Postinfarction LV Remodeling

Ochiai, Koichi; Hu, Qingsong; Lee, Joseph; More

Journal of Cardiovascular Pharmacology . 47(5):686-694, May 2006.

1 2 3 4 5